CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 166 enrolled
Drug / intervention
Tobacco Heating System (THS 2.2) +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01970982
NCT01970982N/ACompleted
CompareCT.gov

A Controlled, 3-arm Parallel Group Study to Demonstrate Reduction in Exposure to Smoke Constituents in Healthy Smokers Switching to THS 2.2 or to Smoking Abstinence, Compared to Conventional Cigarettes for 5 Days in Confinement

Philip Morris Products S.A.·interventional·Posted Oct 28, 2013·Updated Mar 12, 2020

In Brief

A clinical study evaluating Tobacco Heating System (THS 2.2), Smoking abstinence (SA), and 1 other intervention for Smoking. Completed, enrolled 166 participants across 1 site.

Detailed Summary

The overall goal of the study is to evaluate if the ad libitum use of the Tobacco Heating System 2.2 (THS 2.2) for 5 consecutive days by adult Japanese healthy smokers affects the levels of biomarkers of exposure for selected harmful and potentially harmful constituents (HPHCs) compared to smoking conventional cigarettes (CC) and smoking abstinence (SA).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesJapan
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 28, 2013
Enrollment StartJul 1, 2013
Primary CompletionDec 1, 2013
Study CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.7 years ago

Interventions

Tobacco Heating System (THS 2.2)other

THS 2.2 ad libitum for 5 days in confinement

Smoking abstinence (SA)other

SA for 5 days in confinement

Conventional cigarette (CC)other

Subject's own preferred brand of CC ad libitum for 5 days in confinement